Trial Search Results

Investigations of Amygdala Function Using Neurophysiological Recording and Stimulation

This study aims to specifically examine the in vivo electrophysiology and effects of direct stimulation of the human amygdala during conditioned and evoked fear. Investigators will also examine amygdala electrophysiology and the effects of stimulation during tasks to examine the effects of reward on fear memory.

This study will recruit subjects with a history of temporal lobe epilepsy (TLE) who have undergone neurosurgical implantation with FDA-approved, NeuroPace RNS devices for treatment of seizures. These patients provide a unique cohort with (Responsive Neurostimulation) RNS devices capable of both recording and stimulating the amygdala during performance of fear-based, behavioral tasks.

Stanford is currently accepting patients for this trial.

Lead Sponsor:

Stanford University

Collaborator: National Institute of Mental Health (NIMH)

Stanford Investigator(s):

Intervention(s):

  • Device: Amygdala recording and stimulation using Neuropace RNS
  • Behavioral: Behavioral tasks

Phase:

N/A

Eligibility


Inclusion Criteria:

   - be between age 18-65 years of age

   - participants must have received the Neuropace RNS implant to treat their seizures

   - have comprehension of instructions in the English language

   - be on a stable dose of medications for their epilepsy

   - have received the RNS System for Temporal Lobe Epilepsy

   - have capacity to provide informed consent

Exclusion Criteria:

   - significant cognitive impairment (Mini Mental Status Examination score of less than
   20)

   - DSM-V diagnosis of alcohol/substance abuse (except nicotine) within the last month or
   a diagnosis of alcohol/substance dependence (except nicotine) within the last 6 months

   - Unable to apply EEG cap

   - History of traumatic brain injury

   - Active or high suicide risk

   - Unable to come to study site/lack of stable housing

   - is pregnant or nursing

   - Patient's treating neurologist determines that the patient's epilepsy is not stable
   enough to participate in this study

   - Any condition (including psychiatric) which in the judgment of the Investigator would
   prevent the subject from completion of the study

Ages Eligible for Study

18 Years - 65 Years

Genders Eligible for Study

All

Now accepting new patients

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Recruiting